Indeed, we verify that CD44 (a molecular marker for cancer stem cells) is overexpressed in metastatic Luminal A BC SLNs, being also a DEG between the macrometastatic and micrometastatic SLNs (Supplementary Tables S3–S5). The gene discussed is CD44; the disease is breast cancer.